Key Points
- Insider sold: On March 12, director Robert Scavo sold 4,044 shares at an average of $17.45 for about $70,568, reducing his position by 0.80% to 498,970 shares (≈$8.71M).
- Strong revenue growth but still unprofitable: Alignment reported Q4 EPS of ($0.05) beating estimates by $0.10 and revenue of $1.01B (up 44.4% YoY), yet it still posts negative net margin and return on equity.
- Analyst/price context: The consensus rating is "Moderate Buy" with an average target of $24.56; the stock trades near $17, has a $3.47B market cap and a 52-week range of $11.63–$23.87.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Robert Scavo sold 4,044 shares of the company's stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $17.45, for a total transaction of $70,567.80. Following the completion of the transaction, the insider owned 498,970 shares of the company's stock, valued at approximately $8,707,026.50. This trade represents a 0.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Alignment Healthcare Price Performance
NASDAQ:ALHC opened at $16.99 on Friday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The stock's 50-day moving average price is $20.76 and its 200-day moving average price is $18.73. The stock has a market capitalization of $3.47 billion, a PE ratio of -1,697.30, a price-to-earnings-growth ratio of 2.50 and a beta of 1.18.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $0.10. The company had revenue of $1.01 billion during the quarter, compared to analysts' expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.Alignment Healthcare's quarterly revenue was up 44.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.16) EPS. As a group, equities analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on ALHC shares. UBS Group increased their target price on Alignment Healthcare from $18.00 to $21.00 and gave the company a "neutral" rating in a research report on Wednesday, January 14th. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a report on Friday, January 30th. TD Cowen lifted their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a research report on Friday, January 16th. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, March 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $24.56.
Check Out Our Latest Stock Report on Alignment Healthcare
Hedge Funds Weigh In On Alignment Healthcare
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Teacher Retirement System of Texas increased its stake in shares of Alignment Healthcare by 85.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company's stock worth $1,794,000 after acquiring an additional 47,472 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of Alignment Healthcare in the third quarter valued at about $3,499,000. Inspire Investing LLC acquired a new stake in Alignment Healthcare during the third quarter worth about $1,129,000. Ameritas Investment Partners Inc. raised its stake in Alignment Healthcare by 32.9% during the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company's stock worth $182,000 after purchasing an additional 3,225 shares during the period. Finally, Picton Mahoney Asset Management purchased a new position in Alignment Healthcare during the third quarter worth about $6,873,000. Institutional investors and hedge funds own 86.19% of the company's stock.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
